CompletedNot Applicable

Primitive Immunodeficiency and Pregnancy

France99 participantsStarted 2020-11-30

Plain-language summary

The management of patients with primary immune deficiency is increasingly codified, however contraception and pregnancy have not yet extensively studied or codified, and the medical monitoring and the prevention of infectious complications thus remains at the discretion of the practitioner. The aim the research is to study the obstetric features and outcome of patients with primary immune defects.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult woman with Hereditary Immune Deficits and entered in the reference Center for Hereditary Immune Deficits (CEREDIH, hospital Necker-Enfants Malades, Paris) register * Patient having reported at least one pregnancy or attempted pregnancy * Patient not opposing to participation in research Exclusion Criteria: \- Refusal to participate of the study

What they're measuring

Infectious events

Timeframe: 18 months

Trial details

NCT IDNCT04581460

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-04-25

View on ClinicalTrials.gov More Primary Immune Deficiency trials